![](https://ml.globenewswire.com/media/3b61e309-41f2-4de0-be0d-4f67fede819d/small/reshape-lifeciences-logo-jpg.jpg)
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad ...
ReShape and Vyome, a Clinical Stage Specialty Pharmaceutical Company Working To Treat Immuno-Inflammatory Diseases of Unmet Need, to Combine in All-Stock Merger ReShape to Sell its Assets to Affiliate of Biorad Medisys for $5.16 Million IRVINE, Calif. and …